Copied from IHUB......., Fletch falconer66a
Post# of 1460
(Total Views: 505)
Posted On: 11/01/2018 11:27:23 AM
Copied from IHUB.......,
Fletch
falconer66a Thursday, 11/01/18 09:53:35 AM
Re: None 0
Post # of 170633
Ponder the Implications of Sleep Disorders --- And Anavex
A major paper on sleep disorders in the U.S. makes these important points:
Quote:
The International Classification of Sleep Disorders distinguishes more than 80 different disorders, which can be effectively treated. Problems with falling asleep or daytime sleepiness affect approximately 35 to 40% of the U.S. adult population annually and are a significant cause of morbidity and mortality. However, the prevalence, burden, and management of sleep disorders are often ignored or overlooked by individuals and society in general. This leads to an underappreciation and undertreatment of sleep disorders, making this group of illnesses a serious health concern.
https://www.researchgate.net/publication/1129...n_Overview
Ok, so at least a third of American adults have sleep disorders that, “...are a significant cause of morbidity and mortality.”
A far bigger problem than generally recognized — with profound societal implications.
What if most of the Anavex 2-73-dosed Alzheimer’s patients in the upcoming clinical trial start to sleep soundly? (Or, just a third?) Will anything by anyone be made of that?
(For those unfamiliar with the matter, restoration of normal sleep patterns for many was an unexpected finding in the Phase 1 Anavex 2-73 safety and tolerability study for Alzheimer’s patients. Sleep deprivation is a major, complicating symptom of Alzheimer’s disease, currently with no effective treatment.)
https://investorshub.advfn.com/boards/read_ms...=144599308
Fletch
falconer66a Thursday, 11/01/18 09:53:35 AM
Re: None 0
Post # of 170633
Ponder the Implications of Sleep Disorders --- And Anavex
A major paper on sleep disorders in the U.S. makes these important points:
Quote:
The International Classification of Sleep Disorders distinguishes more than 80 different disorders, which can be effectively treated. Problems with falling asleep or daytime sleepiness affect approximately 35 to 40% of the U.S. adult population annually and are a significant cause of morbidity and mortality. However, the prevalence, burden, and management of sleep disorders are often ignored or overlooked by individuals and society in general. This leads to an underappreciation and undertreatment of sleep disorders, making this group of illnesses a serious health concern.
https://www.researchgate.net/publication/1129...n_Overview
Ok, so at least a third of American adults have sleep disorders that, “...are a significant cause of morbidity and mortality.”
A far bigger problem than generally recognized — with profound societal implications.
What if most of the Anavex 2-73-dosed Alzheimer’s patients in the upcoming clinical trial start to sleep soundly? (Or, just a third?) Will anything by anyone be made of that?
(For those unfamiliar with the matter, restoration of normal sleep patterns for many was an unexpected finding in the Phase 1 Anavex 2-73 safety and tolerability study for Alzheimer’s patients. Sleep deprivation is a major, complicating symptom of Alzheimer’s disease, currently with no effective treatment.)
https://investorshub.advfn.com/boards/read_ms...=144599308
(1)
(0)Anavex Life Sciences Corp. (AVXL) Stock Research Links
Scroll down for more posts ▼